Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility

被引:0
|
作者
Ana Osorio
Alicia Barroso
Maria J. García
Beatriz Martínez-Delgado
Miguel Urioste
Javier Benítez
机构
[1] Group of Human Genetics,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
[2] Human Cancer Genetics Programme,undefined
[3] ISCIII,undefined
来源
关键词
Hereditary breast cancer; RAP80; CCDC98; BRCA1;
D O I
暂无
中图分类号
学科分类号
摘要
RAP80 and CCDC98 have arisen as new candidate breast cancer susceptibility genes, since they encode for two very recently identified BRCA1 interacting proteins. In this study we have performed the first mutational analysis of both genes in 168 multiple-case breast/ovarian cancer families, negative for mutations in BRCA1 or BRCA2. We have not found truncating mutations in any of the genes and only two missense variants, p.Tyr564His in RAP80, and p.Met299Ile in CCDC98 were found that could be suspected to have a pathogenic effect, although further analyses suggested that they were probably non deleterious. Our analysis suggests that RAP80 and CCDC98 do not play an important role as high penetrance breast cancer susceptibility genes.
引用
收藏
页码:371 / 376
页数:5
相关论文
共 50 条
  • [1] Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility
    Osorio, Ana
    Barroso, Alicia
    Garcia, Maria J.
    Martinez-Delgado, Beatriz
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (02) : 371 - 376
  • [2] Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases
    Novak, David J.
    Sabbaghian, Nelly
    Maillet, Philippe
    Chappuis, Pierre O.
    Foulkes, William D.
    Tischkowitz, Marc
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (02) : 453 - 459
  • [3] Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases
    David J. Novak
    Nelly Sabbaghian
    Philippe Maillet
    Pierre O. Chappuis
    William D. Foulkes
    Marc Tischkowitz
    Breast Cancer Research and Treatment, 2009, 117 : 453 - 459
  • [4] CCDC98 targets BRCA1 to DNA damage sites
    Zixing Liu
    Jiaxue Wu
    Xiaochun Yu
    Nature Structural & Molecular Biology, 2007, 14 : 716 - 720
  • [5] CCDC98 targets BRCA1 to DNA damage sites
    Liu, Zixing
    Wu, Jiaxue
    Yu, Xiaochun
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (08) : 716 - 720
  • [6] Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families
    Solyom, Szilvia
    Patterson-Fortin, Jeffery
    Pylkas, Katri
    Greenberg, Roger A.
    Winqvist, Robert
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (01) : 165 - 168
  • [7] Germline RAP80 mutations and susceptibility to breast cancer
    Mohammad Reza Akbari
    Parviz Ghadirian
    Andre Robidoux
    Maryam Foumani
    Yulong Sun
    Robert Royer
    Inuk Zandvakili
    Henry Lynch
    Steven A. Narod
    Breast Cancer Research and Treatment, 2009, 113 : 377 - 381
  • [8] Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families
    Szilvia Solyom
    Jeffery Patterson-Fortin
    Katri Pylkäs
    Roger A. Greenberg
    Robert Winqvist
    Breast Cancer Research and Treatment, 2010, 120 : 165 - 168
  • [9] Germline RAP80 mutations and susceptibility to breast cancer
    Akbari, Mohammad Reza
    Ghadirian, Parviz
    Robidoux, Andre
    Foumani, Maryam
    Sun, Yulong
    Royer, Robert
    Zandvakili, Inuk
    Lynch, Henry
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (02) : 377 - 381
  • [10] Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women
    Huo, Xiang
    Lu, Cheng
    Huang, Xinen
    Hu, Zhibin
    Jin, Guangfu
    Ma, Hongxia
    Wang, Xuechen
    Qin, Jianwei
    Wang, Xinru
    Shen, Hongbing
    Tang, Jinhai
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (11) : 1569 - 1575